nodes	percent_of_prediction	percent_of_DWPC	metapath
Fenoldopam—ADRA2A—epilepsy syndrome	0.459	1	CbGaD
Fenoldopam—DRD1—telencephalic ventricle—epilepsy syndrome	0.00641	0.0841	CbGeAlD
Fenoldopam—DRD5—ganglion—epilepsy syndrome	0.00523	0.0685	CbGeAlD
Fenoldopam—DRD1—ganglion—epilepsy syndrome	0.00399	0.0524	CbGeAlD
Fenoldopam—DRD2—telencephalic ventricle—epilepsy syndrome	0.00379	0.0497	CbGeAlD
Fenoldopam—DRD2—ganglion—epilepsy syndrome	0.00236	0.0309	CbGeAlD
Fenoldopam—DRD5—forebrain—epilepsy syndrome	0.00219	0.0287	CbGeAlD
Fenoldopam—DRD5—telencephalon—epilepsy syndrome	0.00202	0.0264	CbGeAlD
Fenoldopam—ADRA1A—hindbrain—epilepsy syndrome	0.00183	0.0239	CbGeAlD
Fenoldopam—DRD2—hindbrain—epilepsy syndrome	0.00179	0.0235	CbGeAlD
Fenoldopam—ADRA1D—forebrain—epilepsy syndrome	0.00176	0.0231	CbGeAlD
Fenoldopam—DRD1—brainstem—epilepsy syndrome	0.00174	0.0228	CbGeAlD
Fenoldopam—DRD1—forebrain—epilepsy syndrome	0.00167	0.022	CbGeAlD
Fenoldopam—ADRA1D—telencephalon—epilepsy syndrome	0.00162	0.0212	CbGeAlD
Fenoldopam—DRD1—telencephalon—epilepsy syndrome	0.00154	0.0202	CbGeAlD
Fenoldopam—DRD5—head—epilepsy syndrome	0.00126	0.0165	CbGeAlD
Fenoldopam—DRD5—nervous system—epilepsy syndrome	0.00119	0.0156	CbGeAlD
Fenoldopam—DRD5—central nervous system—epilepsy syndrome	0.00115	0.015	CbGeAlD
Fenoldopam—DRD1—midbrain—epilepsy syndrome	0.00111	0.0145	CbGeAlD
Fenoldopam—ADRA1A—brainstem—epilepsy syndrome	0.00105	0.0137	CbGeAlD
Fenoldopam—ADRA1B—head—epilepsy syndrome	0.00103	0.0135	CbGeAlD
Fenoldopam—DRD2—brainstem—epilepsy syndrome	0.00103	0.0134	CbGeAlD
Fenoldopam—ADRA1A—forebrain—epilepsy syndrome	0.00101	0.0132	CbGeAlD
Fenoldopam—ADRA1D—head—epilepsy syndrome	0.00101	0.0132	CbGeAlD
Fenoldopam—DRD2—forebrain—epilepsy syndrome	0.00099	0.013	CbGeAlD
Fenoldopam—ADRA1B—nervous system—epilepsy syndrome	0.000975	0.0128	CbGeAlD
Fenoldopam—DRD1—head—epilepsy syndrome	0.000959	0.0126	CbGeAlD
Fenoldopam—ADRA1D—nervous system—epilepsy syndrome	0.000954	0.0125	CbGeAlD
Fenoldopam—ADRA1B—central nervous system—epilepsy syndrome	0.000939	0.0123	CbGeAlD
Fenoldopam—ADRA1A—telencephalon—epilepsy syndrome	0.000928	0.0122	CbGeAlD
Fenoldopam—ADRA1D—central nervous system—epilepsy syndrome	0.000919	0.012	CbGeAlD
Fenoldopam—DRD2—telencephalon—epilepsy syndrome	0.00091	0.0119	CbGeAlD
Fenoldopam—DRD5—brain—epilepsy syndrome	0.00091	0.0119	CbGeAlD
Fenoldopam—DRD1—nervous system—epilepsy syndrome	0.000909	0.0119	CbGeAlD
Fenoldopam—ADRA2C—telencephalon—epilepsy syndrome	0.000885	0.0116	CbGeAlD
Fenoldopam—DRD1—central nervous system—epilepsy syndrome	0.000875	0.0115	CbGeAlD
Fenoldopam—ADRA2A—forebrain—epilepsy syndrome	0.000768	0.0101	CbGeAlD
Fenoldopam—ADRA1B—brain—epilepsy syndrome	0.000746	0.00978	CbGeAlD
Fenoldopam—ADRA1D—brain—epilepsy syndrome	0.000729	0.00956	CbGeAlD
Fenoldopam—ADRA2A—telencephalon—epilepsy syndrome	0.000706	0.00926	CbGeAlD
Fenoldopam—ADRA2C—medulla oblongata—epilepsy syndrome	0.000695	0.00911	CbGeAlD
Fenoldopam—DRD1—brain—epilepsy syndrome	0.000695	0.00911	CbGeAlD
Fenoldopam—DRD2—midbrain—epilepsy syndrome	0.000653	0.00857	CbGeAlD
Fenoldopam—ADRA2C—midbrain—epilepsy syndrome	0.000635	0.00833	CbGeAlD
Fenoldopam—ADRA2C—spinal cord—epilepsy syndrome	0.00062	0.00813	CbGeAlD
Fenoldopam—ADRA1A—head—epilepsy syndrome	0.000578	0.00758	CbGeAlD
Fenoldopam—DRD2—head—epilepsy syndrome	0.000567	0.00743	CbGeAlD
Fenoldopam—ADRA2A—medulla oblongata—epilepsy syndrome	0.000555	0.00727	CbGeAlD
Fenoldopam—ADRA2C—head—epilepsy syndrome	0.000551	0.00722	CbGeAlD
Fenoldopam—ADRA1A—nervous system—epilepsy syndrome	0.000548	0.00719	CbGeAlD
Fenoldopam—DRD2—nervous system—epilepsy syndrome	0.000537	0.00704	CbGeAlD
Fenoldopam—ADRA1A—central nervous system—epilepsy syndrome	0.000528	0.00692	CbGeAlD
Fenoldopam—ADRA2C—nervous system—epilepsy syndrome	0.000522	0.00685	CbGeAlD
Fenoldopam—DRD2—central nervous system—epilepsy syndrome	0.000517	0.00678	CbGeAlD
Fenoldopam—ADRA1A—cerebellum—epilepsy syndrome	0.000516	0.00676	CbGeAlD
Fenoldopam—ADRA2A—midbrain—epilepsy syndrome	0.000507	0.00665	CbGeAlD
Fenoldopam—DRD2—cerebellum—epilepsy syndrome	0.000506	0.00663	CbGeAlD
Fenoldopam—ADRA2C—central nervous system—epilepsy syndrome	0.000503	0.00659	CbGeAlD
Fenoldopam—ADRA2A—spinal cord—epilepsy syndrome	0.000495	0.00649	CbGeAlD
Fenoldopam—ADRA2C—cerebellum—epilepsy syndrome	0.000491	0.00644	CbGeAlD
Fenoldopam—ADRA2A—head—epilepsy syndrome	0.00044	0.00576	CbGeAlD
Fenoldopam—ADRA1A—brain—epilepsy syndrome	0.000419	0.00549	CbGeAlD
Fenoldopam—ADRA2A—nervous system—epilepsy syndrome	0.000417	0.00546	CbGeAlD
Fenoldopam—DRD2—brain—epilepsy syndrome	0.000411	0.00538	CbGeAlD
Fenoldopam—ADRA2A—central nervous system—epilepsy syndrome	0.000401	0.00526	CbGeAlD
Fenoldopam—ADRA2C—brain—epilepsy syndrome	0.000399	0.00523	CbGeAlD
Fenoldopam—ADRA2A—cerebellum—epilepsy syndrome	0.000392	0.00514	CbGeAlD
Fenoldopam—Dyspnoea—Diazepam—epilepsy syndrome	0.000361	0.0014	CcSEcCtD
Fenoldopam—Tachycardia—Clonazepam—epilepsy syndrome	0.000361	0.0014	CcSEcCtD
Fenoldopam—Constipation—Fosphenytoin—epilepsy syndrome	0.000361	0.0014	CcSEcCtD
Fenoldopam—Hypotension—Zonisamide—epilepsy syndrome	0.000359	0.00139	CcSEcCtD
Fenoldopam—Tachycardia—Phenytoin—epilepsy syndrome	0.000359	0.00139	CcSEcCtD
Fenoldopam—Vomiting—Lacosamide—epilepsy syndrome	0.000358	0.00139	CcSEcCtD
Fenoldopam—Blood creatinine increased—Topiramate—epilepsy syndrome	0.000358	0.00138	CcSEcCtD
Fenoldopam—Abdominal pain—Propofol—epilepsy syndrome	0.000358	0.00138	CcSEcCtD
Fenoldopam—Body temperature increased—Propofol—epilepsy syndrome	0.000358	0.00138	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Levetiracetam—epilepsy syndrome	0.000358	0.00138	CcSEcCtD
Fenoldopam—Tachycardia—Oxcarbazepine—epilepsy syndrome	0.000357	0.00138	CcSEcCtD
Fenoldopam—Nausea—Rufinamide—epilepsy syndrome	0.000357	0.00138	CcSEcCtD
Fenoldopam—Hyperhidrosis—Phenytoin—epilepsy syndrome	0.000355	0.00137	CcSEcCtD
Fenoldopam—Insomnia—Felbamate—epilepsy syndrome	0.000355	0.00137	CcSEcCtD
Fenoldopam—Chest pain—Lamotrigine—epilepsy syndrome	0.000354	0.00137	CcSEcCtD
Fenoldopam—Hyperhidrosis—Oxcarbazepine—epilepsy syndrome	0.000354	0.00137	CcSEcCtD
Fenoldopam—Headache—Lacosamide—epilepsy syndrome	0.000353	0.00137	CcSEcCtD
Fenoldopam—Anxiety—Lamotrigine—epilepsy syndrome	0.000353	0.00136	CcSEcCtD
Fenoldopam—Constipation—Vigabatrin—epilepsy syndrome	0.000352	0.00136	CcSEcCtD
Fenoldopam—Dyspnoea—Felbamate—epilepsy syndrome	0.00035	0.00135	CcSEcCtD
Fenoldopam—Orthostatic hypotension—Topiramate—epilepsy syndrome	0.000349	0.00135	CcSEcCtD
Fenoldopam—Bradycardia—Pregabalin—epilepsy syndrome	0.000349	0.00135	CcSEcCtD
Fenoldopam—Hypokalaemia—Topiramate—epilepsy syndrome	0.000348	0.00135	CcSEcCtD
Fenoldopam—Vomiting—Clobazam—epilepsy syndrome	0.000348	0.00134	CcSEcCtD
Fenoldopam—Insomnia—Zonisamide—epilepsy syndrome	0.000347	0.00134	CcSEcCtD
Fenoldopam—Constipation—Diazepam—epilepsy syndrome	0.000347	0.00134	CcSEcCtD
Fenoldopam—Abdominal pain—Levetiracetam—epilepsy syndrome	0.000346	0.00134	CcSEcCtD
Fenoldopam—Body temperature increased—Levetiracetam—epilepsy syndrome	0.000346	0.00134	CcSEcCtD
Fenoldopam—Hypotension—Clonazepam—epilepsy syndrome	0.000346	0.00134	CcSEcCtD
Fenoldopam—Acute coronary syndrome—Gabapentin—epilepsy syndrome	0.000345	0.00133	CcSEcCtD
Fenoldopam—Haemoglobin—Pregabalin—epilepsy syndrome	0.000345	0.00133	CcSEcCtD
Fenoldopam—Hypotension—Phenytoin—epilepsy syndrome	0.000344	0.00133	CcSEcCtD
Fenoldopam—Myocardial infarction—Gabapentin—epilepsy syndrome	0.000343	0.00133	CcSEcCtD
Fenoldopam—Haemorrhage—Pregabalin—epilepsy syndrome	0.000343	0.00133	CcSEcCtD
Fenoldopam—Headache—Clobazam—epilepsy syndrome	0.000343	0.00132	CcSEcCtD
Fenoldopam—Tachycardia—Carbamazepine—epilepsy syndrome	0.000342	0.00132	CcSEcCtD
Fenoldopam—Dyspnoea—Zonisamide—epilepsy syndrome	0.000342	0.00132	CcSEcCtD
Fenoldopam—Hypotension—Oxcarbazepine—epilepsy syndrome	0.000342	0.00132	CcSEcCtD
Fenoldopam—Urinary tract infection—Gabapentin—epilepsy syndrome	0.000341	0.00132	CcSEcCtD
Fenoldopam—Hyperhidrosis—Carbamazepine—epilepsy syndrome	0.000339	0.00131	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Vigabatrin—epilepsy syndrome	0.000337	0.0013	CcSEcCtD
Fenoldopam—Sweating—Gabapentin—epilepsy syndrome	0.000336	0.0013	CcSEcCtD
Fenoldopam—Constipation—Felbamate—epilepsy syndrome	0.000335	0.0013	CcSEcCtD
Fenoldopam—Nausea—Lacosamide—epilepsy syndrome	0.000335	0.00129	CcSEcCtD
Fenoldopam—Insomnia—Clonazepam—epilepsy syndrome	0.000335	0.00129	CcSEcCtD
Fenoldopam—Body temperature increased—Fosphenytoin—epilepsy syndrome	0.000334	0.00129	CcSEcCtD
Fenoldopam—Diarrhoea—Acetazolamide—epilepsy syndrome	0.000334	0.00129	CcSEcCtD
Fenoldopam—Insomnia—Phenytoin—epilepsy syndrome	0.000333	0.00129	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Diazepam—epilepsy syndrome	0.000331	0.00128	CcSEcCtD
Fenoldopam—Tachycardia—Lamotrigine—epilepsy syndrome	0.000331	0.00128	CcSEcCtD
Fenoldopam—Insomnia—Oxcarbazepine—epilepsy syndrome	0.000331	0.00128	CcSEcCtD
Fenoldopam—Dyspnoea—Clonazepam—epilepsy syndrome	0.00033	0.00128	CcSEcCtD
Fenoldopam—Constipation—Zonisamide—epilepsy syndrome	0.000328	0.00127	CcSEcCtD
Fenoldopam—Hypotension—Carbamazepine—epilepsy syndrome	0.000328	0.00127	CcSEcCtD
Fenoldopam—Hyperhidrosis—Lamotrigine—epilepsy syndrome	0.000328	0.00127	CcSEcCtD
Fenoldopam—Dyspnoea—Phenytoin—epilepsy syndrome	0.000328	0.00127	CcSEcCtD
Fenoldopam—Dyspnoea—Oxcarbazepine—epilepsy syndrome	0.000326	0.00126	CcSEcCtD
Fenoldopam—Abdominal pain—Vigabatrin—epilepsy syndrome	0.000325	0.00126	CcSEcCtD
Fenoldopam—Body temperature increased—Vigabatrin—epilepsy syndrome	0.000325	0.00126	CcSEcCtD
Fenoldopam—Nausea—Clobazam—epilepsy syndrome	0.000325	0.00126	CcSEcCtD
Fenoldopam—Tension—Valproic Acid—epilepsy syndrome	0.000324	0.00125	CcSEcCtD
Fenoldopam—Dizziness—Acetazolamide—epilepsy syndrome	0.000323	0.00125	CcSEcCtD
Fenoldopam—Angina pectoris—Topiramate—epilepsy syndrome	0.000322	0.00124	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Felbamate—epilepsy syndrome	0.000321	0.00124	CcSEcCtD
Fenoldopam—Nervousness—Valproic Acid—epilepsy syndrome	0.000321	0.00124	CcSEcCtD
Fenoldopam—Abdominal pain—Diazepam—epilepsy syndrome	0.00032	0.00124	CcSEcCtD
Fenoldopam—Bradycardia—Gabapentin—epilepsy syndrome	0.00032	0.00124	CcSEcCtD
Fenoldopam—Back pain—Valproic Acid—epilepsy syndrome	0.000319	0.00123	CcSEcCtD
Fenoldopam—ADRA2A—brain—epilepsy syndrome	0.000319	0.00418	CbGeAlD
Fenoldopam—Flushing—Pregabalin—epilepsy syndrome	0.000318	0.00123	CcSEcCtD
Fenoldopam—Muscle spasms—Valproic Acid—epilepsy syndrome	0.000317	0.00123	CcSEcCtD
Fenoldopam—Insomnia—Carbamazepine—epilepsy syndrome	0.000317	0.00123	CcSEcCtD
Fenoldopam—Constipation—Clonazepam—epilepsy syndrome	0.000317	0.00122	CcSEcCtD
Fenoldopam—Haemorrhage—Gabapentin—epilepsy syndrome	0.000314	0.00122	CcSEcCtD
Fenoldopam—Constipation—Phenytoin—epilepsy syndrome	0.000314	0.00122	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Zonisamide—epilepsy syndrome	0.000314	0.00121	CcSEcCtD
Fenoldopam—Dyspnoea—Carbamazepine—epilepsy syndrome	0.000313	0.00121	CcSEcCtD
Fenoldopam—Constipation—Oxcarbazepine—epilepsy syndrome	0.000313	0.00121	CcSEcCtD
Fenoldopam—Abdominal pain—Felbamate—epilepsy syndrome	0.00031	0.0012	CcSEcCtD
Fenoldopam—Body temperature increased—Felbamate—epilepsy syndrome	0.00031	0.0012	CcSEcCtD
Fenoldopam—Vomiting—Acetazolamide—epilepsy syndrome	0.00031	0.0012	CcSEcCtD
Fenoldopam—Diarrhoea—Propofol—epilepsy syndrome	0.00031	0.0012	CcSEcCtD
Fenoldopam—Insomnia—Lamotrigine—epilepsy syndrome	0.000307	0.00119	CcSEcCtD
Fenoldopam—Headache—Acetazolamide—epilepsy syndrome	0.000306	0.00118	CcSEcCtD
Fenoldopam—Body temperature increased—Zonisamide—epilepsy syndrome	0.000304	0.00117	CcSEcCtD
Fenoldopam—Abdominal pain—Zonisamide—epilepsy syndrome	0.000304	0.00117	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Clonazepam—epilepsy syndrome	0.000303	0.00117	CcSEcCtD
Fenoldopam—Dyspnoea—Lamotrigine—epilepsy syndrome	0.000302	0.00117	CcSEcCtD
Fenoldopam—Constipation—Carbamazepine—epilepsy syndrome	0.0003	0.00116	CcSEcCtD
Fenoldopam—Dizziness—Propofol—epilepsy syndrome	0.0003	0.00116	CcSEcCtD
Fenoldopam—Diarrhoea—Levetiracetam—epilepsy syndrome	0.000299	0.00116	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Oxcarbazepine—epilepsy syndrome	0.000299	0.00116	CcSEcCtD
Fenoldopam—Dizziness—Midazolam—epilepsy syndrome	0.000293	0.00113	CcSEcCtD
Fenoldopam—Tension—Pregabalin—epilepsy syndrome	0.000293	0.00113	CcSEcCtD
Fenoldopam—Abdominal pain—Clonazepam—epilepsy syndrome	0.000293	0.00113	CcSEcCtD
Fenoldopam—Body temperature increased—Clonazepam—epilepsy syndrome	0.000293	0.00113	CcSEcCtD
Fenoldopam—Palpitations—Valproic Acid—epilepsy syndrome	0.000292	0.00113	CcSEcCtD
Fenoldopam—Body temperature increased—Phenytoin—epilepsy syndrome	0.000291	0.00112	CcSEcCtD
Fenoldopam—Constipation—Lamotrigine—epilepsy syndrome	0.00029	0.00112	CcSEcCtD
Fenoldopam—Nervousness—Pregabalin—epilepsy syndrome	0.00029	0.00112	CcSEcCtD
Fenoldopam—Nausea—Acetazolamide—epilepsy syndrome	0.00029	0.00112	CcSEcCtD
Fenoldopam—Dizziness—Levetiracetam—epilepsy syndrome	0.000289	0.00112	CcSEcCtD
Fenoldopam—Body temperature increased—Oxcarbazepine—epilepsy syndrome	0.000289	0.00112	CcSEcCtD
Fenoldopam—Abdominal pain—Oxcarbazepine—epilepsy syndrome	0.000289	0.00112	CcSEcCtD
Fenoldopam—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.000289	0.00112	CcSEcCtD
Fenoldopam—Back pain—Pregabalin—epilepsy syndrome	0.000289	0.00112	CcSEcCtD
Fenoldopam—Vomiting—Propofol—epilepsy syndrome	0.000288	0.00111	CcSEcCtD
Fenoldopam—Muscle spasms—Pregabalin—epilepsy syndrome	0.000287	0.00111	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Carbamazepine—epilepsy syndrome	0.000287	0.00111	CcSEcCtD
Fenoldopam—Urinary tract infection—Topiramate—epilepsy syndrome	0.000286	0.00111	CcSEcCtD
Fenoldopam—Headache—Propofol—epilepsy syndrome	0.000284	0.0011	CcSEcCtD
Fenoldopam—Vomiting—Midazolam—epilepsy syndrome	0.000282	0.00109	CcSEcCtD
Fenoldopam—Diarrhoea—Vigabatrin—epilepsy syndrome	0.000282	0.00109	CcSEcCtD
Fenoldopam—Chest pain—Valproic Acid—epilepsy syndrome	0.000281	0.00109	CcSEcCtD
Fenoldopam—Anxiety—Valproic Acid—epilepsy syndrome	0.00028	0.00108	CcSEcCtD
Fenoldopam—Dizziness—Fosphenytoin—epilepsy syndrome	0.000279	0.00108	CcSEcCtD
Fenoldopam—Vomiting—Levetiracetam—epilepsy syndrome	0.000278	0.00108	CcSEcCtD
Fenoldopam—Headache—Midazolam—epilepsy syndrome	0.000278	0.00107	CcSEcCtD
Fenoldopam—Abdominal pain—Carbamazepine—epilepsy syndrome	0.000277	0.00107	CcSEcCtD
Fenoldopam—Body temperature increased—Carbamazepine—epilepsy syndrome	0.000277	0.00107	CcSEcCtD
Fenoldopam—Diarrhoea—Diazepam—epilepsy syndrome	0.000277	0.00107	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	0.000277	0.00107	CcSEcCtD
Fenoldopam—Headache—Levetiracetam—epilepsy syndrome	0.000274	0.00106	CcSEcCtD
Fenoldopam—Dizziness—Vigabatrin—epilepsy syndrome	0.000272	0.00105	CcSEcCtD
Fenoldopam—Bradycardia—Topiramate—epilepsy syndrome	0.000269	0.00104	CcSEcCtD
Fenoldopam—Nausea—Propofol—epilepsy syndrome	0.000269	0.00104	CcSEcCtD
Fenoldopam—Tension—Gabapentin—epilepsy syndrome	0.000269	0.00104	CcSEcCtD
Fenoldopam—Vomiting—Fosphenytoin—epilepsy syndrome	0.000269	0.00104	CcSEcCtD
Fenoldopam—Diarrhoea—Felbamate—epilepsy syndrome	0.000268	0.00104	CcSEcCtD
Fenoldopam—Abdominal pain—Lamotrigine—epilepsy syndrome	0.000268	0.00104	CcSEcCtD
Fenoldopam—Body temperature increased—Lamotrigine—epilepsy syndrome	0.000268	0.00104	CcSEcCtD
Fenoldopam—Dizziness—Diazepam—epilepsy syndrome	0.000268	0.00104	CcSEcCtD
Fenoldopam—Haemoglobin—Topiramate—epilepsy syndrome	0.000266	0.00103	CcSEcCtD
Fenoldopam—Nervousness—Gabapentin—epilepsy syndrome	0.000266	0.00103	CcSEcCtD
Fenoldopam—Back pain—Gabapentin—epilepsy syndrome	0.000265	0.00102	CcSEcCtD
Fenoldopam—Headache—Fosphenytoin—epilepsy syndrome	0.000265	0.00102	CcSEcCtD
Fenoldopam—Haemorrhage—Topiramate—epilepsy syndrome	0.000265	0.00102	CcSEcCtD
Fenoldopam—Palpitations—Pregabalin—epilepsy syndrome	0.000264	0.00102	CcSEcCtD
Fenoldopam—Nausea—Midazolam—epilepsy syndrome	0.000263	0.00102	CcSEcCtD
Fenoldopam—Muscle spasms—Gabapentin—epilepsy syndrome	0.000263	0.00102	CcSEcCtD
Fenoldopam—Tachycardia—Valproic Acid—epilepsy syndrome	0.000263	0.00102	CcSEcCtD
Fenoldopam—Diarrhoea—Zonisamide—epilepsy syndrome	0.000263	0.00102	CcSEcCtD
Fenoldopam—Vomiting—Vigabatrin—epilepsy syndrome	0.000262	0.00101	CcSEcCtD
Fenoldopam—Hyperhidrosis—Valproic Acid—epilepsy syndrome	0.000261	0.00101	CcSEcCtD
Fenoldopam—Nausea—Levetiracetam—epilepsy syndrome	0.00026	0.001	CcSEcCtD
Fenoldopam—Dizziness—Felbamate—epilepsy syndrome	0.000259	0.001	CcSEcCtD
Fenoldopam—Headache—Vigabatrin—epilepsy syndrome	0.000258	0.000997	CcSEcCtD
Fenoldopam—Vomiting—Diazepam—epilepsy syndrome	0.000258	0.000996	CcSEcCtD
Fenoldopam—Chest pain—Pregabalin—epilepsy syndrome	0.000254	0.000982	CcSEcCtD
Fenoldopam—Dizziness—Zonisamide—epilepsy syndrome	0.000254	0.000981	CcSEcCtD
Fenoldopam—Headache—Diazepam—epilepsy syndrome	0.000254	0.000981	CcSEcCtD
Fenoldopam—Anxiety—Pregabalin—epilepsy syndrome	0.000253	0.000979	CcSEcCtD
Fenoldopam—Diarrhoea—Clonazepam—epilepsy syndrome	0.000253	0.000979	CcSEcCtD
Fenoldopam—Hypotension—Valproic Acid—epilepsy syndrome	0.000252	0.000973	CcSEcCtD
Fenoldopam—Diarrhoea—Phenytoin—epilepsy syndrome	0.000252	0.000972	CcSEcCtD
Fenoldopam—Nausea—Fosphenytoin—epilepsy syndrome	0.000251	0.00097	CcSEcCtD
Fenoldopam—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.00025	0.000967	CcSEcCtD
Fenoldopam—Vomiting—Felbamate—epilepsy syndrome	0.000249	0.000964	CcSEcCtD
Fenoldopam—Headache—Felbamate—epilepsy syndrome	0.000246	0.00095	CcSEcCtD
Fenoldopam—Flushing—Topiramate—epilepsy syndrome	0.000246	0.000949	CcSEcCtD
Fenoldopam—Dizziness—Clonazepam—epilepsy syndrome	0.000245	0.000946	CcSEcCtD
Fenoldopam—Nausea—Vigabatrin—epilepsy syndrome	0.000245	0.000945	CcSEcCtD
Fenoldopam—Vomiting—Zonisamide—epilepsy syndrome	0.000244	0.000944	CcSEcCtD
Fenoldopam—Insomnia—Valproic Acid—epilepsy syndrome	0.000244	0.000942	CcSEcCtD
Fenoldopam—Dizziness—Phenytoin—epilepsy syndrome	0.000243	0.00094	CcSEcCtD
Fenoldopam—Palpitations—Gabapentin—epilepsy syndrome	0.000242	0.000935	CcSEcCtD
Fenoldopam—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000242	0.000935	CcSEcCtD
Fenoldopam—Nausea—Diazepam—epilepsy syndrome	0.000241	0.000931	CcSEcCtD
Fenoldopam—Headache—Zonisamide—epilepsy syndrome	0.000241	0.00093	CcSEcCtD
Fenoldopam—Dyspnoea—Valproic Acid—epilepsy syndrome	0.00024	0.000929	CcSEcCtD
Fenoldopam—Diarrhoea—Carbamazepine—epilepsy syndrome	0.00024	0.000928	CcSEcCtD
Fenoldopam—Tachycardia—Pregabalin—epilepsy syndrome	0.000238	0.000919	CcSEcCtD
Fenoldopam—Hyperhidrosis—Pregabalin—epilepsy syndrome	0.000236	0.00091	CcSEcCtD
Fenoldopam—Vomiting—Clonazepam—epilepsy syndrome	0.000235	0.000909	CcSEcCtD
Fenoldopam—Vomiting—Phenytoin—epilepsy syndrome	0.000234	0.000903	CcSEcCtD
Fenoldopam—Chest pain—Gabapentin—epilepsy syndrome	0.000233	0.000901	CcSEcCtD
Fenoldopam—Nausea—Felbamate—epilepsy syndrome	0.000233	0.000901	CcSEcCtD
Fenoldopam—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000233	0.000899	CcSEcCtD
Fenoldopam—Anxiety—Gabapentin—epilepsy syndrome	0.000232	0.000898	CcSEcCtD
Fenoldopam—Dizziness—Carbamazepine—epilepsy syndrome	0.000232	0.000897	CcSEcCtD
Fenoldopam—Diarrhoea—Lamotrigine—epilepsy syndrome	0.000232	0.000897	CcSEcCtD
Fenoldopam—Headache—Clonazepam—epilepsy syndrome	0.000232	0.000896	CcSEcCtD
Fenoldopam—Constipation—Valproic Acid—epilepsy syndrome	0.00023	0.000891	CcSEcCtD
Fenoldopam—Headache—Phenytoin—epilepsy syndrome	0.00023	0.00089	CcSEcCtD
Fenoldopam—Headache—Oxcarbazepine—epilepsy syndrome	0.000229	0.000885	CcSEcCtD
Fenoldopam—Nausea—Zonisamide—epilepsy syndrome	0.000228	0.000882	CcSEcCtD
Fenoldopam—Hypotension—Pregabalin—epilepsy syndrome	0.000228	0.00088	CcSEcCtD
Fenoldopam—Tension—Topiramate—epilepsy syndrome	0.000226	0.000873	CcSEcCtD
Fenoldopam—Dizziness—Lamotrigine—epilepsy syndrome	0.000224	0.000867	CcSEcCtD
Fenoldopam—Nervousness—Topiramate—epilepsy syndrome	0.000224	0.000865	CcSEcCtD
Fenoldopam—Vomiting—Carbamazepine—epilepsy syndrome	0.000223	0.000862	CcSEcCtD
Fenoldopam—Back pain—Topiramate—epilepsy syndrome	0.000223	0.000861	CcSEcCtD
Fenoldopam—Muscle spasms—Topiramate—epilepsy syndrome	0.000221	0.000856	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	0.00022	0.000852	CcSEcCtD
Fenoldopam—Insomnia—Pregabalin—epilepsy syndrome	0.00022	0.000852	CcSEcCtD
Fenoldopam—Nausea—Clonazepam—epilepsy syndrome	0.00022	0.00085	CcSEcCtD
Fenoldopam—Headache—Carbamazepine—epilepsy syndrome	0.00022	0.00085	CcSEcCtD
Fenoldopam—Nausea—Phenytoin—epilepsy syndrome	0.000218	0.000844	CcSEcCtD
Fenoldopam—Tachycardia—Gabapentin—epilepsy syndrome	0.000218	0.000843	CcSEcCtD
Fenoldopam—Dyspnoea—Pregabalin—epilepsy syndrome	0.000217	0.00084	CcSEcCtD
Fenoldopam—Nausea—Oxcarbazepine—epilepsy syndrome	0.000217	0.000839	CcSEcCtD
Fenoldopam—Hyperhidrosis—Gabapentin—epilepsy syndrome	0.000216	0.000835	CcSEcCtD
Fenoldopam—Vomiting—Lamotrigine—epilepsy syndrome	0.000216	0.000833	CcSEcCtD
Fenoldopam—Abdominal pain—Valproic Acid—epilepsy syndrome	0.000213	0.000823	CcSEcCtD
Fenoldopam—Body temperature increased—Valproic Acid—epilepsy syndrome	0.000213	0.000823	CcSEcCtD
Fenoldopam—Headache—Lamotrigine—epilepsy syndrome	0.000212	0.000821	CcSEcCtD
Fenoldopam—Hypotension—Gabapentin—epilepsy syndrome	0.000209	0.000807	CcSEcCtD
Fenoldopam—Nausea—Carbamazepine—epilepsy syndrome	0.000208	0.000806	CcSEcCtD
Fenoldopam—Constipation—Pregabalin—epilepsy syndrome	0.000208	0.000805	CcSEcCtD
Fenoldopam—Palpitations—Topiramate—epilepsy syndrome	0.000204	0.000787	CcSEcCtD
Fenoldopam—Insomnia—Gabapentin—epilepsy syndrome	0.000202	0.000781	CcSEcCtD
Fenoldopam—Nausea—Lamotrigine—epilepsy syndrome	0.000201	0.000779	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Pregabalin—epilepsy syndrome	0.000199	0.00077	CcSEcCtD
Fenoldopam—Dyspnoea—Gabapentin—epilepsy syndrome	0.000199	0.00077	CcSEcCtD
Fenoldopam—Chest pain—Topiramate—epilepsy syndrome	0.000196	0.000758	CcSEcCtD
Fenoldopam—Anxiety—Topiramate—epilepsy syndrome	0.000195	0.000755	CcSEcCtD
Fenoldopam—Body temperature increased—Pregabalin—epilepsy syndrome	0.000193	0.000744	CcSEcCtD
Fenoldopam—Abdominal pain—Pregabalin—epilepsy syndrome	0.000193	0.000744	CcSEcCtD
Fenoldopam—Constipation—Gabapentin—epilepsy syndrome	0.000191	0.000738	CcSEcCtD
Fenoldopam—Diarrhoea—Valproic Acid—epilepsy syndrome	0.000184	0.000713	CcSEcCtD
Fenoldopam—Tachycardia—Topiramate—epilepsy syndrome	0.000183	0.000709	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Gabapentin—epilepsy syndrome	0.000183	0.000706	CcSEcCtD
Fenoldopam—Hyperhidrosis—Topiramate—epilepsy syndrome	0.000182	0.000702	CcSEcCtD
Fenoldopam—Dizziness—Valproic Acid—epilepsy syndrome	0.000178	0.000689	CcSEcCtD
Fenoldopam—Abdominal pain—Gabapentin—epilepsy syndrome	0.000177	0.000683	CcSEcCtD
Fenoldopam—Body temperature increased—Gabapentin—epilepsy syndrome	0.000177	0.000683	CcSEcCtD
Fenoldopam—Hypotension—Topiramate—epilepsy syndrome	0.000176	0.000679	CcSEcCtD
Fenoldopam—Vomiting—Valproic Acid—epilepsy syndrome	0.000171	0.000662	CcSEcCtD
Fenoldopam—Insomnia—Topiramate—epilepsy syndrome	0.00017	0.000657	CcSEcCtD
Fenoldopam—Headache—Valproic Acid—epilepsy syndrome	0.000169	0.000653	CcSEcCtD
Fenoldopam—Dyspnoea—Topiramate—epilepsy syndrome	0.000168	0.000648	CcSEcCtD
Fenoldopam—Diarrhoea—Pregabalin—epilepsy syndrome	0.000167	0.000644	CcSEcCtD
Fenoldopam—Dizziness—Pregabalin—epilepsy syndrome	0.000161	0.000623	CcSEcCtD
Fenoldopam—Constipation—Topiramate—epilepsy syndrome	0.000161	0.000621	CcSEcCtD
Fenoldopam—Nausea—Valproic Acid—epilepsy syndrome	0.00016	0.000619	CcSEcCtD
Fenoldopam—Vomiting—Pregabalin—epilepsy syndrome	0.000155	0.000599	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Topiramate—epilepsy syndrome	0.000154	0.000594	CcSEcCtD
Fenoldopam—Diarrhoea—Gabapentin—epilepsy syndrome	0.000153	0.000591	CcSEcCtD
Fenoldopam—Headache—Pregabalin—epilepsy syndrome	0.000153	0.00059	CcSEcCtD
Fenoldopam—Body temperature increased—Topiramate—epilepsy syndrome	0.000149	0.000574	CcSEcCtD
Fenoldopam—Abdominal pain—Topiramate—epilepsy syndrome	0.000149	0.000574	CcSEcCtD
Fenoldopam—Dizziness—Gabapentin—epilepsy syndrome	0.000148	0.000571	CcSEcCtD
Fenoldopam—Nausea—Pregabalin—epilepsy syndrome	0.000145	0.000559	CcSEcCtD
Fenoldopam—Vomiting—Gabapentin—epilepsy syndrome	0.000142	0.000549	CcSEcCtD
Fenoldopam—Headache—Gabapentin—epilepsy syndrome	0.00014	0.000541	CcSEcCtD
Fenoldopam—Nausea—Gabapentin—epilepsy syndrome	0.000133	0.000513	CcSEcCtD
Fenoldopam—Diarrhoea—Topiramate—epilepsy syndrome	0.000129	0.000497	CcSEcCtD
Fenoldopam—Dizziness—Topiramate—epilepsy syndrome	0.000124	0.00048	CcSEcCtD
Fenoldopam—Vomiting—Topiramate—epilepsy syndrome	0.00012	0.000462	CcSEcCtD
Fenoldopam—Headache—Topiramate—epilepsy syndrome	0.000118	0.000455	CcSEcCtD
Fenoldopam—Nausea—Topiramate—epilepsy syndrome	0.000112	0.000431	CcSEcCtD
Fenoldopam—ADRA2A—Signaling Pathways—PLCB1—epilepsy syndrome	7.71e-06	3.74e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—FYN—epilepsy syndrome	7.7e-06	3.73e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—AVP—epilepsy syndrome	7.7e-06	3.73e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—POMC—epilepsy syndrome	7.69e-06	3.73e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—H2AFX—epilepsy syndrome	7.67e-06	3.72e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—HMOX1—epilepsy syndrome	7.67e-06	3.72e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—MEF2C—epilepsy syndrome	7.66e-06	3.71e-05	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—MTOR—epilepsy syndrome	7.57e-06	3.67e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—CAT—epilepsy syndrome	7.57e-06	3.67e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—ADAM10—epilepsy syndrome	7.56e-06	3.66e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—HTR7—epilepsy syndrome	7.55e-06	3.66e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—CCL2—epilepsy syndrome	7.53e-06	3.65e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—TSC2—epilepsy syndrome	7.43e-06	3.6e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—AGT—epilepsy syndrome	7.42e-06	3.6e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—S100B—epilepsy syndrome	7.42e-06	3.6e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—YWHAZ—epilepsy syndrome	7.4e-06	3.59e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—HES1—epilepsy syndrome	7.4e-06	3.58e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—AGT—epilepsy syndrome	7.39e-06	3.58e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—ABCB1—epilepsy syndrome	7.36e-06	3.57e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—SOCS3—epilepsy syndrome	7.35e-06	3.56e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—TSC2—epilepsy syndrome	7.33e-06	3.55e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CDC42—epilepsy syndrome	7.33e-06	3.55e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—HBEGF—epilepsy syndrome	7.33e-06	3.55e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—AGT—epilepsy syndrome	7.32e-06	3.55e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—NGF—epilepsy syndrome	7.32e-06	3.55e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—HES1—epilepsy syndrome	7.28e-06	3.53e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—APOE—epilepsy syndrome	7.27e-06	3.52e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—APOE—epilepsy syndrome	7.24e-06	3.51e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—FYN—epilepsy syndrome	7.19e-06	3.49e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—AKT3—epilepsy syndrome	7.19e-06	3.49e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—APOE—epilepsy syndrome	7.18e-06	3.48e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—H2AFX—epilepsy syndrome	7.17e-06	3.47e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—MEF2C—epilepsy syndrome	7.15e-06	3.47e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—S100B—epilepsy syndrome	7.15e-06	3.46e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—POMC—epilepsy syndrome	7.15e-06	3.46e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—KDR—epilepsy syndrome	7.12e-06	3.45e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CCR5—epilepsy syndrome	7.12e-06	3.45e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—AVP—epilepsy syndrome	7.1e-06	3.44e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—SOCS3—epilepsy syndrome	7.08e-06	3.43e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—FYN—epilepsy syndrome	7.08e-06	3.43e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CDC42—epilepsy syndrome	7.06e-06	3.42e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—H2AFX—epilepsy syndrome	7.05e-06	3.42e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—MEF2C—epilepsy syndrome	7.04e-06	3.41e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—KDR—epilepsy syndrome	7.03e-06	3.41e-05	CbGpPWpGaD
Fenoldopam—DRD5—GPCR downstream signaling—AKT1—epilepsy syndrome	7.03e-06	3.4e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—ADAM10—epilepsy syndrome	7.03e-06	3.4e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—CCL2—epilepsy syndrome	6.99e-06	3.39e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—HTR2A—epilepsy syndrome	6.97e-06	3.38e-05	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—CASP3—epilepsy syndrome	6.96e-06	3.37e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—YWHAZ—epilepsy syndrome	6.92e-06	3.35e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—PRKCB—epilepsy syndrome	6.86e-06	3.32e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—GPX1—epilepsy syndrome	6.84e-06	3.32e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—AVP—epilepsy syndrome	6.84e-06	3.31e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—NGF—epilepsy syndrome	6.84e-06	3.31e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—IL6ST—epilepsy syndrome	6.83e-06	3.31e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—YWHAZ—epilepsy syndrome	6.81e-06	3.3e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—PRKCB—epilepsy syndrome	6.77e-06	3.28e-05	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—JUN—epilepsy syndrome	6.76e-06	3.28e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—IL6ST—epilepsy syndrome	6.74e-06	3.27e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—NGF—epilepsy syndrome	6.73e-06	3.26e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—HES1—epilepsy syndrome	6.71e-06	3.25e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CCR5—epilepsy syndrome	6.65e-06	3.22e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—S100B—epilepsy syndrome	6.64e-06	3.22e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—TSC2—epilepsy syndrome	6.62e-06	3.21e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—AGT—epilepsy syndrome	6.61e-06	3.2e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Hemostasis—AKT1—epilepsy syndrome	6.58e-06	3.19e-05	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—MMP9—epilepsy syndrome	6.58e-06	3.19e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—SOCS3—epilepsy syndrome	6.58e-06	3.19e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CDC42—epilepsy syndrome	6.56e-06	3.18e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CCR5—epilepsy syndrome	6.55e-06	3.17e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—FYN—epilepsy syndrome	6.53e-06	3.16e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—HTR2A—epilepsy syndrome	6.51e-06	3.15e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—H2AFX—epilepsy syndrome	6.5e-06	3.15e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—MEF2C—epilepsy syndrome	6.49e-06	3.15e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—APOE—epilepsy syndrome	6.48e-06	3.14e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—HES1—epilepsy syndrome	6.47e-06	3.13e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—HTR2A—epilepsy syndrome	6.41e-06	3.1e-05	CbGpPWpGaD
Fenoldopam—DRD5—Signaling by GPCR—AKT1—epilepsy syndrome	6.38e-06	3.09e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—AVP—epilepsy syndrome	6.35e-06	3.08e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—KDR—epilepsy syndrome	6.35e-06	3.08e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—FYN—epilepsy syndrome	6.29e-06	3.05e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—YWHAZ—epilepsy syndrome	6.27e-06	3.04e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—H2AFX—epilepsy syndrome	6.27e-06	3.04e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—MEF2C—epilepsy syndrome	6.25e-06	3.03e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—POMC—epilepsy syndrome	6.25e-06	3.03e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—POMC—epilepsy syndrome	6.22e-06	3.01e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—NGF—epilepsy syndrome	6.2e-06	3.01e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—TSC2—epilepsy syndrome	6.18e-06	3e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—AGT—epilepsy syndrome	6.18e-06	2.99e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—POMC—epilepsy syndrome	6.16e-06	2.99e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Hemostasis—AKT1—epilepsy syndrome	6.15e-06	2.98e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—CCL2—epilepsy syndrome	6.11e-06	2.96e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—PRKCB—epilepsy syndrome	6.11e-06	2.96e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—TSC2—epilepsy syndrome	6.09e-06	2.95e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—IL6ST—epilepsy syndrome	6.08e-06	2.95e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—AGT—epilepsy syndrome	6.08e-06	2.95e-05	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—SRC—epilepsy syndrome	6.07e-06	2.94e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—APOE—epilepsy syndrome	6.05e-06	2.93e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—YWHAZ—epilepsy syndrome	6.05e-06	2.93e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CCR5—epilepsy syndrome	6.04e-06	2.92e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—CCL2—epilepsy syndrome	6.03e-06	2.92e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—HES1—epilepsy syndrome	6.01e-06	2.91e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—AGT—epilepsy syndrome	6e-06	2.91e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—NGF—epilepsy syndrome	5.98e-06	2.9e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—APOE—epilepsy syndrome	5.96e-06	2.89e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—KDR—epilepsy syndrome	5.93e-06	2.87e-05	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—VEGFA—epilepsy syndrome	5.91e-06	2.86e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—HTR2A—epilepsy syndrome	5.91e-06	2.86e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—APOE—epilepsy syndrome	5.88e-06	2.85e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—FYN—epilepsy syndrome	5.84e-06	2.83e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—KDR—epilepsy syndrome	5.83e-06	2.83e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—H2AFX—epilepsy syndrome	5.82e-06	2.82e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CCR5—epilepsy syndrome	5.81e-06	2.82e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—MEF2C—epilepsy syndrome	5.81e-06	2.82e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—PRKCB—epilepsy syndrome	5.71e-06	2.77e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—HTR2A—epilepsy syndrome	5.69e-06	2.76e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—IL6ST—epilepsy syndrome	5.68e-06	2.75e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—ALB—epilepsy syndrome	5.67e-06	2.75e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—YWHAZ—epilepsy syndrome	5.62e-06	2.72e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—PRKCB—epilepsy syndrome	5.62e-06	2.72e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—TSC2—epilepsy syndrome	5.61e-06	2.72e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—AGT—epilepsy syndrome	5.6e-06	2.72e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—IL6ST—epilepsy syndrome	5.59e-06	2.71e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—POMC—epilepsy syndrome	5.57e-06	2.7e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—NGF—epilepsy syndrome	5.55e-06	2.69e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—FGF2—epilepsy syndrome	5.52e-06	2.68e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—APOE—epilepsy syndrome	5.49e-06	2.66e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—FGF2—epilepsy syndrome	5.45e-06	2.64e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CCL2—epilepsy syndrome	5.45e-06	2.64e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—TSC2—epilepsy syndrome	5.41e-06	2.62e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CCR5—epilepsy syndrome	5.4e-06	2.62e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—AGT—epilepsy syndrome	5.4e-06	2.62e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—KDR—epilepsy syndrome	5.38e-06	2.61e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—APOE—epilepsy syndrome	5.29e-06	2.56e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—HTR2A—epilepsy syndrome	5.29e-06	2.56e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—POMC—epilepsy syndrome	5.2e-06	2.52e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—KDR—epilepsy syndrome	5.18e-06	2.51e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—PRKCB—epilepsy syndrome	5.18e-06	2.51e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—IL6ST—epilepsy syndrome	5.16e-06	2.5e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—RELA—epilepsy syndrome	5.13e-06	2.48e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—POMC—epilepsy syndrome	5.12e-06	2.48e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CCL2—epilepsy syndrome	5.09e-06	2.46e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—RELA—epilepsy syndrome	5.06e-06	2.45e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—POMC—epilepsy syndrome	5.05e-06	2.45e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—MTOR—epilepsy syndrome	5.03e-06	2.44e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—TSC2—epilepsy syndrome	5.02e-06	2.43e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—AGT—epilepsy syndrome	5.02e-06	2.43e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CCL2—epilepsy syndrome	5.01e-06	2.43e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Hemostasis—AKT1—epilepsy syndrome	4.99e-06	2.42e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—PRKCB—epilepsy syndrome	4.99e-06	2.42e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—IL6ST—epilepsy syndrome	4.97e-06	2.41e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—MTOR—epilepsy syndrome	4.96e-06	2.4e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—PTGS2—epilepsy syndrome	4.96e-06	2.4e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—FGF2—epilepsy syndrome	4.92e-06	2.38e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—APOE—epilepsy syndrome	4.92e-06	2.38e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—KDR—epilepsy syndrome	4.82e-06	2.33e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—POMC—epilepsy syndrome	4.72e-06	2.29e-05	CbGpPWpGaD
Fenoldopam—DRD1—GPCR downstream signaling—AKT1—epilepsy syndrome	4.67e-06	2.26e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—PRKCB—epilepsy syndrome	4.64e-06	2.25e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—CASP3—epilepsy syndrome	4.63e-06	2.24e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—IL6ST—epilepsy syndrome	4.62e-06	2.24e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CCL2—epilepsy syndrome	4.62e-06	2.24e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR downstream signaling—AKT1—epilepsy syndrome	4.61e-06	2.23e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—ALB—epilepsy syndrome	4.6e-06	2.23e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—FGF2—epilepsy syndrome	4.6e-06	2.23e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—RELA—epilepsy syndrome	4.57e-06	2.21e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—CASP3—epilepsy syndrome	4.56e-06	2.21e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—POMC—epilepsy syndrome	4.54e-06	2.2e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—FGF2—epilepsy syndrome	4.52e-06	2.19e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—JUN—epilepsy syndrome	4.49e-06	2.18e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—MTOR—epilepsy syndrome	4.48e-06	2.17e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CCL2—epilepsy syndrome	4.45e-06	2.15e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—JUN—epilepsy syndrome	4.43e-06	2.15e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—MMP9—epilepsy syndrome	4.37e-06	2.12e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—MMP9—epilepsy syndrome	4.31e-06	2.09e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—RELA—epilepsy syndrome	4.27e-06	2.07e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—AKT1—epilepsy syndrome	4.24e-06	2.05e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—POMC—epilepsy syndrome	4.22e-06	2.05e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—RELA—epilepsy syndrome	4.2e-06	2.04e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—MTOR—epilepsy syndrome	4.18e-06	2.03e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—AKT1—epilepsy syndrome	4.18e-06	2.03e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—FGF2—epilepsy syndrome	4.17e-06	2.02e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—AKT1—epilepsy syndrome	4.16e-06	2.02e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CCL2—epilepsy syndrome	4.13e-06	2e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CASP3—epilepsy syndrome	4.12e-06	2e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—MTOR—epilepsy syndrome	4.12e-06	2e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—SRC—epilepsy syndrome	4.03e-06	1.95e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—PTGS2—epilepsy syndrome	4.03e-06	1.95e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—FGF2—epilepsy syndrome	4.02e-06	1.95e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—JUN—epilepsy syndrome	4e-06	1.94e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—SRC—epilepsy syndrome	3.98e-06	1.93e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—VEGFA—epilepsy syndrome	3.93e-06	1.9e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—MMP9—epilepsy syndrome	3.89e-06	1.89e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—AKT1—epilepsy syndrome	3.88e-06	1.88e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—VEGFA—epilepsy syndrome	3.87e-06	1.88e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—RELA—epilepsy syndrome	3.87e-06	1.88e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CASP3—epilepsy syndrome	3.85e-06	1.87e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—AKT1—epilepsy syndrome	3.82e-06	1.85e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—MTOR—epilepsy syndrome	3.8e-06	1.84e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CASP3—epilepsy syndrome	3.79e-06	1.84e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—AKT1—epilepsy syndrome	3.78e-06	1.83e-05	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—AKT1—epilepsy syndrome	3.77e-06	1.83e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—JUN—epilepsy syndrome	3.74e-06	1.81e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—FGF2—epilepsy syndrome	3.73e-06	1.81e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—RELA—epilepsy syndrome	3.73e-06	1.81e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—JUN—epilepsy syndrome	3.68e-06	1.78e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—MTOR—epilepsy syndrome	3.66e-06	1.77e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—MMP9—epilepsy syndrome	3.64e-06	1.76e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—SRC—epilepsy syndrome	3.59e-06	1.74e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—MMP9—epilepsy syndrome	3.58e-06	1.73e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—AKT1—epilepsy syndrome	3.53e-06	1.71e-05	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—AKT1—epilepsy syndrome	3.52e-06	1.71e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—VEGFA—epilepsy syndrome	3.5e-06	1.69e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CASP3—epilepsy syndrome	3.49e-06	1.69e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—AKT1—epilepsy syndrome	3.47e-06	1.68e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—RELA—epilepsy syndrome	3.47e-06	1.68e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—MTOR—epilepsy syndrome	3.4e-06	1.65e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—AKT1—epilepsy syndrome	3.4e-06	1.65e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—JUN—epilepsy syndrome	3.39e-06	1.64e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CASP3—epilepsy syndrome	3.36e-06	1.63e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—SRC—epilepsy syndrome	3.35e-06	1.62e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—SRC—epilepsy syndrome	3.3e-06	1.6e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—MMP9—epilepsy syndrome	3.3e-06	1.6e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—JUN—epilepsy syndrome	3.27e-06	1.58e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—VEGFA—epilepsy syndrome	3.27e-06	1.58e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—VEGFA—epilepsy syndrome	3.21e-06	1.56e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—AKT1—epilepsy syndrome	3.2e-06	1.55e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—MMP9—epilepsy syndrome	3.18e-06	1.54e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—AKT1—epilepsy syndrome	3.16e-06	1.53e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CASP3—epilepsy syndrome	3.13e-06	1.51e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—AKT1—epilepsy syndrome	3.08e-06	1.49e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—SRC—epilepsy syndrome	3.04e-06	1.47e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—JUN—epilepsy syndrome	3.04e-06	1.47e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—VEGFA—epilepsy syndrome	2.96e-06	1.44e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—MMP9—epilepsy syndrome	2.95e-06	1.43e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—SRC—epilepsy syndrome	2.93e-06	1.42e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—AKT1—epilepsy syndrome	2.87e-06	1.39e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—VEGFA—epilepsy syndrome	2.86e-06	1.38e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—SRC—epilepsy syndrome	2.72e-06	1.32e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—VEGFA—epilepsy syndrome	2.65e-06	1.29e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—AKT1—epilepsy syndrome	2.5e-06	1.21e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—AKT1—epilepsy syndrome	2.49e-06	1.21e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—AKT1—epilepsy syndrome	2.47e-06	1.2e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—AKT1—epilepsy syndrome	2.23e-06	1.08e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—AKT1—epilepsy syndrome	2.08e-06	1.01e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—AKT1—epilepsy syndrome	2.05e-06	9.94e-06	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—AKT1—epilepsy syndrome	2.02e-06	9.81e-06	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—AKT1—epilepsy syndrome	1.89e-06	9.16e-06	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—AKT1—epilepsy syndrome	1.82e-06	8.83e-06	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—AKT1—epilepsy syndrome	1.69e-06	8.2e-06	CbGpPWpGaD
